Trademark: 97040176
Word
INTELLISELECT
Status
Registered
Status Code
700
Status Date
Tuesday, May 23, 2023
Serial Number
97040176
Registration Number
7058471
Registration Date
Tuesday, May 23, 2023
Mark Type
4000
Filing Date
Wednesday, September 22, 2021
Published for Opposition
Tuesday, March 7, 2023

Trademark Owner History
Kymab Limited - Original Registrant

Classifications
9 Downloadable computer software for use in scientific and pharmaceutical research and development for identifying, creating or selecting antibody or antigen binding fragment thereof, or sequences and nucleic acids encoding them; downloadable computer software for scientific modelling antibodies and antigen binding fragment thereof; downloadable computer software for pharmaceutical modelling; downloadable computer software for research and development in the field of antibodies discovery
5 Pharmaceutical preparations for the prevention of diseases and disorders caused by bacteria; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of diseases of the immune system; preparations for detecting genetic predispositions for medical purposes; chemical preparations for medical use in DNA analysis; medicines for treating bacterial diseases and disorders, cancer, and immune-system diseases and disorders; vaccines; human vaccine preparations; vaccines for human use
44 Medical diagnostic testing, monitoring and reporting services; DNA screening for medical purposes; genetic analysis and reporting services for medical purposes in relation to the treatment of persons; medical services relating to DNA, genetics and genetic testing; genetic counselling
42 Research and development services in the medical and pharmaceuticals field of medicines, genetics, antibodies, oncology, immunology and inflammatory diseases and disorders; design and development of computer hardware and software; clinical research in the field of antibodies, oncology, immunology and inflammatory diseases and disorders; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; structural and functional analysis of genomes; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; biotechnology testing and research to discover antibodies and pharmaceutical substances ; research in the field of medicines; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals; medical research services; providing information in medical research concerning pharmaceutical substances
In the statement, Column 1, line 2," (B390)" should be deleted, and (B930) should be inserted.

Trademark Events
Mar 15, 2024
Correction Under Section 7 - Processed
Mar 11, 2024
Case Assigned To Post Registration Paralegal
Jul 18, 2023
Teas Section 7 Request Received
May 23, 2023
Notice Of Registration Confirmation Emailed
May 23, 2023
Registered-Principal Register
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2023
Published For Opposition
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Jan 26, 2023
Approved For Pub - Principal Register
Dec 21, 2022
Teas/Email Correspondence Entered
Dec 21, 2022
Correspondence Received In Law Office
Dec 21, 2022
Teas Response To Office Action Received
Jun 23, 2022
Notification Of Non-Final Action E-Mailed
Jun 23, 2022
Non-Final Action E-Mailed
Jun 23, 2022
Non-Final Action Written
Jun 23, 2022
Assigned To Examiner
Oct 28, 2021
Preliminary/Voluntary Amendment - Entered
Oct 28, 2021
Assigned To Lie
Oct 4, 2021
Teas Voluntary Amendment Received
Oct 5, 2021
Teas Voluntary Amendment Received
Oct 25, 2021
New Application Office Supplied Data Entered
Sep 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24